RETRACTED ARTICLE: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression

Rui Yang, Lei Xing, Xiaying Zheng, +3

Molecular Cancer

Use of a Dense Single Nucleotide Polymorphism Map for In Silico Mapping in the Mouse

Mathew T. Pletcher, Philip McClurg, Serge Batalov, +10

PLoS Biology

GeneticsHuman PolymorphismMolecular GeneticsSingle Gene TraitsDisease Gene Identification +17

Haplotype Analysis in Multiple Crosses to Identify a QTL Gene

Xiao‐Song Wang, Ron Korstanje, David Higgins, +1

Genome Research

Using Advanced Intercross Lines for High-Resolution Mapping of HDL Cholesterol Quantitative Trait Loci

Xiao‐Song Wang, Isabelle Le Roy, Edwige Nicodème, +9

Genome Research

<i>THADA</i> fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer

Federica Panebianco, Lindsey Kelly, Pengyuan Liu, +17

Proceedings of the National Academy of Sciences

Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: significance of genetic background for assessing atherosclerosis

Xiao‐Song Wang, Shelley A. Phelan, Christina Petros, +5

Atherosclerosis

InflammationVascular DiseasePeroxiredoxin 6Atherosclerosis SusceptibilityDisease Mechanism +11

Landscape analysis of adjacent gene rearrangements reveals BCL2L14–ETV6 gene fusions in more aggressive triple-negative breast cancer

Sang Hoon Lee, Yiheng Hu, Suet Kee Loo, +4

Proceedings of the National Academy of Sciences

Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug

Xianzhou Song, Chengwei Zhang, Mingkun Zhao, +10

PLoS ONE

A Torrid Zone on Mouse Chromosome 1 Containing a Cluster of Recombinational Hotspots

Peter M. Kelmenson, Petko M. Petkov, Xiao‐Song Wang, +3

Genetics

GeneticsMolecular BiologyMolecular GeneticsGenomicsReproductive Biology +15

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity

Xian Wang, Ying Tan, Xixi Cao, +5

Oncotarget